BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15989224)

  • 1. [Construction and characterization of Salmonella typhimurium SL7207 SifA- mutant strain].
    Zhang XM; Jiao XA; Tang LH; Pan ZM; Yin YL
    Wei Sheng Wu Xue Bao; 2005 Jun; 45(3):349-54. PubMed ID: 15989224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella enterica serovar Typhimurium interaction with dendritic cells: impact of the sifA gene.
    Petrovska L; Aspinall RJ; Barber L; Clare S; Simmons CP; Stratford R; Khan SA; Lemoine NR; Frankel G; Holden DW; Dougan G
    Cell Microbiol; 2004 Nov; 6(11):1071-84. PubMed ID: 15469435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attenuated Salmonella typhimurium as DNA delivery vehicle for DNA-mediated immunization].
    He P; Chen H; Liu JX; Chen SY; Hu BY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):238-42. PubMed ID: 15640857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.
    Nagy G; Danino V; Dobrindt U; Pallen M; Chaudhuri R; Emödy L; Hinton JC; Hacker J
    Infect Immun; 2006 Oct; 74(10):5914-25. PubMed ID: 16988271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The related effector proteins SopD and SopD2 from Salmonella enterica serovar Typhimurium contribute to virulence during systemic infection of mice.
    Jiang X; Rossanese OW; Brown NF; Kujat-Choy S; Galán JE; Finlay BB; Brumell JH
    Mol Microbiol; 2004 Dec; 54(5):1186-98. PubMed ID: 15554961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction and immunogenicity of attenuated Salmonella typhimurium harbouring stable DNA vaccine against H5 subtype of avian influenza virus].
    Tang LH; Pan ZM; Cheng NN; Jiao XA; Zhang XM
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):662-6. PubMed ID: 17944368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction, safety and immunogenicity analysis of attenuated salmonella typhimurium harbouring TGEV DNA vaccine].
    Yang H; Liu J; Cao S; Huang X; Wen X
    Wei Sheng Wu Xue Bao; 2009 Jan; 49(1):72-7. PubMed ID: 19388267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein].
    Chen ZH; Zhao P; Wu SM; Cao J; Zhang B; Wan MB; Ke JS; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):862-6. PubMed ID: 18051866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the two-component regulator CpxAR in the virulence of Salmonella enterica serotype Typhimurium.
    Humphreys S; Rowley G; Stevenson A; Anjum MF; Woodward MJ; Gilbert S; Kormanec J; Roberts M
    Infect Immun; 2004 Aug; 72(8):4654-61. PubMed ID: 15271926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and efficacy of attenuated Salmonella typhimurium harbouring DNA vaccine against Newcastle disease virus].
    Pan ZM; Jiao XA; Huang JL; Yin YL; Tang LH; Zhang H; Zhang XM; Zhang XR; Liu XF
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):937-41. PubMed ID: 16496707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenicity of S1 gene DNA vaccine of mouse hepatitis virus delivered by attenuated Salmonella typhimurium].
    Jiao HM; Jiao XA; Yin YL; Pan ZM; Meng SS; Wang Y; Jiang JJ
    Wei Sheng Wu Xue Bao; 2007 Feb; 47(1):131-5. PubMed ID: 17436639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited role for SsrA/B in persistent Salmonella Typhimurium infections in pigs.
    Boyen F; Pasmans F; Van Immerseel F; Morgan E; Botteldoorn N; Heyndrickx M; Volf J; Favoreel H; Hernalsteens JP; Ducatelle R; Haesebrouck F
    Vet Microbiol; 2008 Apr; 128(3-4):364-73. PubMed ID: 18068913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated Salmonella typhimurium htrA mutants cause fatal infections in mice deficient in NADPH oxidase and destroy NADPH oxidase-deficient macrophage monolayers.
    Mutunga M; Graham S; De Hormaeche RD; Musson JA; Robinson JH; Mastroeni P; Khan CM; Hormaeche CE
    Vaccine; 2004 Sep; 22(29-30):4124-31. PubMed ID: 15364466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhancement by an in vivo-activated promoter of immunogenicity of recombinant attenuated Salmonella typhimurium expressing hepatitis C virus core antigen].
    Zhao P; Ke S; Wang HW; Qian F; Qi ZT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):266-70. PubMed ID: 12621552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular immune responses specific for CD8+ T cell epitopes delivered by attenuated Salmonella typhimurium].
    Zhang H; Jiao XA; Pan ZM; Zhang XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):137-40. PubMed ID: 16507242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel strains of Salmonella typhimurium as potential vectors for gene delivery.
    Michael A; Stratford R; Khan S; Dalgleish A; Pandha H
    FEMS Microbiol Lett; 2004 Sep; 238(2):345-51. PubMed ID: 15358419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.
    Denich K; Börlin P; O'Hanley PD; Howard M; Heath AW
    Infect Immun; 1993 Nov; 61(11):4818-27. PubMed ID: 8406883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary activities of SseJ and SifA regulate dynamics of the Salmonella typhimurium vacuolar membrane.
    Ruiz-Albert J; Yu XJ; Beuzón CR; Blakey AN; Galyov EE; Holden DW
    Mol Microbiol; 2002 May; 44(3):645-61. PubMed ID: 11994148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and immunogenicity of attenuated Salmonella typhimurium stably harbouring DNA vaccine against Newcastle disease virus].
    Pan ZM; Huang JL; Cheng NN; Cui YC; You M; Tang LH; Zhang XM; Jiao XA; Liu XF
    Bing Du Xue Bao; 2008 Jan; 24(1):41-6. PubMed ID: 18320821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.